Nebuliser devices for drug delivery in cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Hughes, Tracey ^a   Mills, Nicola ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; DORNASE ALFA; SODIUM CHLORIDE; TOBRAMYCIN; ANTIBIOTIC AGENT;

CLINICAL TRIAL; DRUG COST; DRUG DELIVERY SYSTEM; HUMAN; LUNG FIBROSIS; LUNG FUNCTION TEST; NEBULIZER; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; AEROSOL; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; EVALUATION; LONG TERM CARE; MEDICAL NEBULIZER; NEBULIZATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; RELIABILITY; RISK ASSESSMENT; SAFETY;

EID: 70249151377     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007639     Document Type: Review

References (12)

1. Cantin A. Cystic Fibrosis lung inflammation: early, sustained and severe. American Journal of Respiratory and Critical Care Medicine 1995;151(4):939-941
2. CF Foundation. National Patient Registry. Annual Data Report [Bethesda, Maryland] 2006.
3. Elbourne, D.R, Altman, D.G, Higgins, J.P.T, Curtin, F, Worthington, H.V, Vail, A.Meta-analyses involving cross-over trials: methodological issues.. International Journal of Epidemiology 2002;31(1): 140-149
4. Halfhide C, Evans HJ, Couriel J. Inhaled bronchodilators for cystic fibrosis. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD003428.pub2]
5. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-560
6. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration 2008. Available from www.cochrane-handbook.org.
7. Hodson M. Treatment of cystic fibrosis in the adult. Respiration 2000;67(6):595-607.
8. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatric Pulomonolgy 1997;24(2):137-142
9. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
10. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery AB, et al.Defining a pulmonary exacerbation in cystic fibrosis. Journal of Pediatrics 2001;139(3):359-365
11. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. Journal of Pediatrics 1998;132(4):589-595 [PUBMED: 9580754 ]
12. Zach MS. Lung disease in Cystic Fibrosis - an updated concept. Pediatric Pulmonology 1990;8(3):188-202.